Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fortress Biotech (FBIO) Debt to Equity (2016 - 2025)

Fortress Biotech (FBIO) has 13 years of Debt to Equity data on record, last reported at $0.73 in Q3 2025.

  • For Q3 2025, Debt to Equity rose 117.79% year-over-year to $0.73; the TTM value through Sep 2025 reached $0.73, up 117.79%, while the annual FY2024 figure was -$35.26, 191.94% down from the prior year.
  • Debt to Equity reached $0.73 in Q3 2025 per FBIO's latest filing, down from $1.34 in the prior quarter.
  • Across five years, Debt to Equity topped out at $38.35 in Q4 2023 and bottomed at -$35.26 in Q4 2024.
  • Average Debt to Equity over 5 years is -$0.77, with a median of $0.21 recorded in 2021.
  • The widest YoY moves for Debt to Equity: up 1991.23% in 2023, down 590.57% in 2023.
  • A 5-year view of Debt to Equity shows it stood at $0.19 in 2021, then soared by 864.64% to $1.83 in 2022, then skyrocketed by 1991.23% to $38.35 in 2023, then crashed by 191.94% to -$35.26 in 2024, then skyrocketed by 102.08% to $0.73 in 2025.
  • Per Business Quant database, its latest 3 readings for Debt to Equity were $0.73 in Q3 2025, $1.34 in Q2 2025, and $1.74 in Q1 2025.